Search Within

Department of Medicine

  1. "Taylor & Francis Group"
Formats
  1. Journal Article (290)
  2. Review (29)
  3. Meeting Abstract (24)
  4. Research Letter (11)
  5. Correspondence (10)
  6. Book Section (9)
  7. Editorial (9)
  8. Conference Paper (5)
  9. Book Whole (2)
  10. Guidelines (1)
Groups
  1. Hematologic Malignancies, Division of (277)
  2. Center for Hematologic Malignancies (252)
  3. Survivorship Research (103)
  4. Lymphoma (92)
  5. Solid Tumor Oncology Division (91)
  6. Adult Leukemia (87)

More Groups

People
  1. Sergio Giralt (35)
  2. Andrew Zelenetz (31)
  3. Martin Tallman (28)
  4. Steven Horwitz (23)
  5. Hani Hassoun (21)
  6. Heather Landau (21)

More People

Years
  1. 2025 (16)
  2. 2024 (13)
  3. 2023 (17)
  4. 2022 (23)
  5. 2021 (19)
  6. 2020 (38)

More Years

Publications
  1. Leukemia and Lymphoma (227)
  2. Expert Review of Anticancer Therapy (33)
  3. Women's Oncology Review (18)
  4. Expert Review of Hematology (15)
  5. Cancer Biology and Therapy (14)
  6. Amyloid (13)

More Publications

Publishers
  1. Taylor & Francis Group (390)

Results (390)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Advances in the treatment of high burden follicular lymphoma: A comprehensive review
    Review

    Luttwak, E.; Kumar, A.; Salles, G.
    Leukemia and Lymphoma (2025)

    Fulltext@MSK | Save
  • Pneumocystis jirovecii pneumonia with use of brentuximab vedotin in treatment-naïve Hodgkin lymphoma
    Correspondence

    Gurumurthi, A.; Henshaw, L.; Falchi, L.; Moskowitz, A.; Noy, A.; Seo, S.; Stuver, R.
    Leukemia and Lymphoma (2025)

    Fulltext@MSK | Save
  • Hematology-oncology provider perspectives regarding lymphoma treatment and cardioprotective strategies in patients with lymphoma at high risk for heart failure
    Journal Article

    Anderson, E.; Choi, Y.; Buchsbaum, R. J.; Klein, A.; Ky, B.; Landsburg, D.; Durani, U.; Ruddy, K. J.; Yu, A. F.; Leong, D.; more...
    Leukemia and Lymphoma (2025)

    Fulltext@MSK | Save
  • Outcomes of T-cell/histiocyte-rich large B-cell lymphoma treated with higher-intensity therapy in the rituximab era: Insights from a retrospective analysis
    Journal Article

    Luttwak, E.; Robin, E. T.; Drill, E.; Boardman, A.; Caron, P.; Epstein-Peterson, Z.; Falchi, L.; Ghione, P.; Hamlin, P. A.; Horwitz, S. M.; more...
    Leukemia and Lymphoma (2025)

    Fulltext@MSK | Save
  • Five-year molecular response and overall survival with first- and second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia in the chronic phase: A prospective, observational study–SIMPLICITY
    Journal Article

    Mauro, M. J.; Hehlmann, R.; Williams, L. A.; Goldberg, S. L.; Michallet, M.; Gambacorti-Passerini, C.; Tang, D.; DeGutis, I. S.; McBride, A.; Parsons, L.; more...
    Leukemia and Lymphoma (2025)

    Fulltext@MSK | Save
  • Ibrutinib added to standard conditioning and as maintenance therapy following autologous hematopoietic stem cell transplantation for relapsed or refractory activated-B-cell type Diffuse Large B-cell lymphoma: Primary analysis of the US intergroup double-blind randomized phase III study Alliance A051301/BMT-CTN 1201
    Editorial

    Andreadis, C.; Bobek, O.; Hsi, E. D.; Fenske, T. S.; Stiff, P. J.; Hill, B. T.; Geyer, S. M.; Horwitz, M.; Khimani, F.; Little, R. F.; more...
    Leukemia and Lymphoma (2025)

    Fulltext@MSK | Save
  • BCMA-targeting BiTE molecule AMG 420 in relapsed or refractory multiple myeloma: A phase 1b open-label expansion study
    Journal Article

    Rodriguez, C.; Rodriguez, T.; Kentos, A.; Driessen, C.; Suanmi, K.; Lesokhin, A. M.; Yee, A. J.; Minella, A. C.; Maraboina, R.; Upreti, V. V.; more...
    Leukemia and Lymphoma (2025)

    Fulltext@MSK | Save
  • Results from an open-label phase 2a study of cerdulatinib, a dual spleen tyrosine kinase/janus kinase inhibitor, in relapsed/refractory peripheral T-cell lymphoma
    Journal Article

    Horwitz, S. M.; Feldman, T. A.; Ye, J. C.; Khodadoust, M. S.; Munoz, J.; Hamlin, P. A.; Kim, Y. H.; Wilcox, R. A.; Patel, M. R.; Coffey, G.; more...
    Leukemia and Lymphoma (2025)

    Fulltext@MSK | Save
  • Identifying people with acute lymphoblastic leukemia who are most suitable for treatment with inotuzumab ozogamicin: A plain language summary
    Review

    Marks, D. I.; Cassaday, R. D.; Ribera, J. M.; Schuh, A. C.; Park, J. H.; Chiaretti, S.; Stelljes, M.
    Expert Review of Hematology (2025)

    Fulltext@MSK | Save
  • gneSeqCOO: A novel method for classifying diffuse large B-cell lymphoma cell of origin based on bulk tumor RNA sequencing profiles
    Journal Article

    Harris, W.; Cao, Y.; Morschhauser, F.; Salles, G.; Jiang, Y.; Bottos, A.; Lenz, G.; Bolen, C. R.
    Leukemia and Lymphoma (2025)

    Fulltext@MSK | Save